0 0 0 0 0 0 0 0
Sign Up Today X
Thanks for submitting the form.
Stockreport

BioMarin Pharmaceuticals: Amicus Transforms Business Case Overnight [Seeking Alpha]

BioMarin Pharmaceutical Inc. (BMRN)  More Company Research Source: Seeking Alpha
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
BMRN pays a steep premium—over 8x sales—for Amicus, aiming to diversify growth engines in rare diseases. The deal is expected to be accretive to 2027 earnings, but immediate gross leverage rises to 3.0–3.5x, with a target to deleverage below 2.5x in two years. Despite the premium and leverage, BMRN's shares surged, reflecting optimism about pipeline synergies but warranting caution after the valuation run-up. Catherine Delahaye/DigitalVision via Getty Images By the end of October, I concluded that BioMarin Pharmaceutical Inc. ( BMRN ) was showing growing numbers, yet it came with falling expectations. Shares had fallen to the lowest levels in a decade, despite profitable growth More on my IG service If you like to see more ideas, please subscribe to the premium service "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide cover [Read more]
IMPACT SNAPSHOT EVENT TIME: BMRN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
BMRN alerts
from News Quantified
BMRN
NEWS
BMRN
Earnings
BMRN
Analyst Actions
BMRN
SEC Filings
Stockreport

BioMarin Pharmaceuticals: Amicus Transforms Business Case Overnight [Seeking Alpha]

BioMarin Pharmaceutical Inc.  (BMRN) 
More Company Research Source: Seeking Alpha
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
BMRN pays a steep premium—over 8x sales—for Amicus, aiming to diversify growth engines in rare diseases. The deal is expected to be accretive to 2027 earnings, but immediate gross leverage rises to 3.0–3.5x, with a target to deleverage below 2.5x in two years. Despite the premium and leverage, BMRN's shares surged, reflecting optimism about pipeline synergies but warranting caution after the valuation run-up. Catherine Delahaye/DigitalVision via Getty Images By the end of October, I concluded that BioMarin Pharmaceutical Inc. ( BMRN ) was showing growing numbers, yet it came with falling expectations. Shares had fallen to the lowest levels in a decade, despite profitable growth More on my IG service If you like to see more ideas, please subscribe to the premium service "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide cover [Read more]
IMPACT SNAPSHOT
EVENT TIME:
BMRN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS